ctrl K

Watchlist Price Alert

Bicara Therapeutics Inc. ... (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

9.40

-0.27 (-2.79%)

At close: Jun 18, 2025, 2:07 PM

Bicara Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q1 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Mar 31, 2023
Cash & Equivalents	462.06M	489.71M	520.76M	203.85M	203.85M	230.44M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.63M	65.82M	2.12M	2.09M	2.09M	2.09M	-4.16M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.69M	12.82M	756K	2.22M	n/a	633K	n/a
Total Current Assets	470.75M	502.53M	521.51M	206.08M	206.08M	231.07M	4.16M
Property-Plant & Equipment	688K	845K	544K	619K	619K	815K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.32M	66.66M	2.66M	2.71M	2.71M	2.91M	-4.16M
Total Assets	478.08M	510M	524.17M	208.78M	208.78M	233.98M	n/a
Account Payables	2.35M	4.51M	1.96M	4.68M	4.68M	3.19M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	591K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.17M	3.08M	1.81M	1.12M	n/a	1.74M	n/a
Total Current Liabilities	19.12M	17.99M	14.48M	16.07M	16.07M	15.09M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	367.28M	n/a	367.29M	17.28M
Total Long-Term Liabilities	n/a	131K	137K	367.49M	217K	367.67M	17.28M
Total Liabilities	19.12M	18.12M	14.62M	383.56M	16.28M	382.75M	17.28M
Total Debt	591K	738K	445K	517K	517K	657K	n/a
Common Stock	7K	7K	7K	2K	2K	2K	n/a
Retained Earnings	-257.86M	-221.02M	-200.06M	-182.58M	-182.58M	-153.02M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00	n/a	-98.8M
Shareholders Equity	458.96M	491.88M	509.56M	-174.78M	192.5M	-148.77M	-17.28M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a